Immune-inflammatory endotypes of chronic rhinosinusitis: from epithelial alarmins to personalized therapy - Takeaways - MDSpire

Immune-Inflammatory Endotypes in Chronic Rhinosinusitis: From Epithelial Alarmins to Tailored Treatment Approaches

  • By

  • Hanxiong Li

  • Longting Wang

  • Dingbo Li

  • July 17, 2026

Share

  • 1

    Chronic rhinosinusitis (CRS) is classified into two phenotypes: with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP).

  • 2

    Traditional phenotypic classifications of CRS do not adequately capture the disease's underlying pathophysiological heterogeneity.

  • 3

    Immunological endotyping identifies distinct inflammatory pathways in CRS, including type 1, type 2, and type 3 immune responses.

  • 4

    Epithelial-derived cytokines and immune cells play critical roles in modulating the immune landscape of CRS.

  • 5

    Geographical and ethnic differences affect the prevalence of CRS endotypes, highlighting the need for tailored diagnostic and therapeutic approaches.

Original Source(s)

Immune-inflammatory endotypes of chronic rhinosinusitis: from epithelial alarmins to personalized therapy

  • by Hanxiong Li, Longting Wang, Dingbo Li

  • July 17, 2026

Related Content

Multi-omics integration and in vitro validation identify IL4R, IMPA2, and PRR4 as key therapeutic targets in chronic rhinosinusitis with nasal polyps

Diagnostic value and immune microenvironment regulatory network of metabolic reprogramming in chronic rhinosinusitis with nasal polyps identified by multidimensional transcriptome integration and machine learning

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.